Formula Growth Ltd. lowered its holdings in Health Care SPDR (NYSE:XLV) by 1.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 55,000 shares of the exchange traded fund’s stock after selling 1,000 shares during the period. Formula Growth Ltd.’s holdings in Health Care SPDR were worth $4,358,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the stock. JPMorgan Chase & Co. grew its position in Health Care SPDR by 1.0% in the second quarter. JPMorgan Chase & Co. now owns 5,318,485 shares of the exchange traded fund’s stock valued at $421,437,000 after purchasing an additional 54,138 shares in the last quarter. Ameriprise Financial Inc. grew its position in Health Care SPDR by 60.5% in the second quarter. Ameriprise Financial Inc. now owns 2,400,209 shares of the exchange traded fund’s stock valued at $190,410,000 after purchasing an additional 904,476 shares in the last quarter. Janney Montgomery Scott LLC grew its position in Health Care SPDR by 2.6% in the second quarter. Janney Montgomery Scott LLC now owns 1,470,955 shares of the exchange traded fund’s stock valued at $116,559,000 after purchasing an additional 37,824 shares in the last quarter. Schroder Investment Management Group bought a new position in Health Care SPDR in the second quarter valued at $84,476,000. Finally, AGF Investments Inc. grew its position in Health Care SPDR by 10.9% in the second quarter. AGF Investments Inc. now owns 1,028,416 shares of the exchange traded fund’s stock valued at $78,946,000 after purchasing an additional 101,209 shares in the last quarter.

Health Care SPDR (NYSE XLV) traded down 0.33% on Friday, reaching $81.31. 1,915,951 shares of the company were exchanged. The company’s 50-day moving average price is $80.28 and its 200-day moving average price is $77.60. Health Care SPDR has a 12-month low of $65.96 and a 12-month high of $83.41.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Monday, September 18th will be issued a dividend of $0.3048 per share. The ex-dividend date of this dividend is Friday, September 15th. This represents a $1.22 annualized dividend and a yield of 1.49%.

TRADEMARK VIOLATION WARNING: “Formula Growth Ltd. Has $4.36 Million Position in Health Care SPDR (XLV)” was reported by Daily Political and is the property of of Daily Political. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://www.dailypolitical.com/2017/09/22/formula-growth-ltd-has-4-36-million-position-in-health-care-spdr-xlv.html.

Health Care SPDR Profile

Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor’s 500 Composite Stock Index (S&P 500).

Want to see what other hedge funds are holding XLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Health Care SPDR (NYSE:XLV).

Institutional Ownership by Quarter for Health Care SPDR (NYSE:XLV)

Receive News & Ratings for Health Care SPDR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Care SPDR and related companies with MarketBeat.com's FREE daily email newsletter.